angiogenesis comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-03-27. Numbers and descriptions here follow the published literature rather than marketing material.
Most published studies examine BPC-157 in animal models rather than in humans. Common subjects include rats and mice, and researchers often use models of tissue injury, surgery, or induced inflammation. Reported endpoints include healing rates, blood vessel formation, and markers of tissue repair. These designs provide controlled comparisons, but findings in animals do not automatically transfer to people. Human clinical data remain limited and are frequently described as preliminary.
Doses in the literature are usually expressed in micrograms or nanograms per kilogram of body weight. Investigators have administered the peptide by several routes, including injection and oral delivery, depending on the question asked. Route and dose vary widely across studies, which complicates direct comparison of results. Many papers report effects at low doses, but the absence of a standardized protocol limits generalization. Reporting practice differs between research groups.
Once dissolved, the material is considerably less stable than the dry solid. Aqueous solutions are usually kept cold and used within a short window, and neutral or mildly acidic buffers are preferred over strongly alkaline conditions. Freeze-thaw cycles promote aggregation and loss of material to container surfaces, so dividing a batch into single-use aliquots is standard. Adsorption to plastic and glass can lower the measured concentration, meaning solution strength may need rechecking before an experiment.
Identity and purity are established with complementary methods rather than one test. Reverse-phase high-performance liquid chromatography separates the main peak from deletion sequences and oxidized variants, and its area percentage is the usual purity figure. Mass spectrometry confirms the expected molecular mass and can flag truncations or modifications that chromatography alone might miss. Amino acid analysis and peptide mapping add sequence-level confirmation, while residual counter-ion and water content are measured separately.
A freeze-dried sample is generally the most stable form and is commonly held at minus twenty degrees Celsius or lower for long-term keeping, with brief transfers at room temperature. The solid is hygroscopic, so vials are warmed to ambient temperature before opening to prevent condensation from degrading the contents. Light exposure and repeated temperature cycling are both avoided in routine handling. Storage over a desiccant is a common laboratory practice that limits moisture uptake during repeated access.
| Property | Value | Notes |
|---|---|---|
| Typical subjects | Rats and mice | Animal models |
| Common routes | Injection and oral | Route varies by study |
| Reported dose range | Microgram to milligram per kg | Not standardized across work |
| Frequent endpoints | Tissue repair, angiogenesis | Marker-dependent |
| Human evidence | Limited | Mostly small or preliminary studies |
Outside laboratory supply channels, the peptide is sold as a research chemical, a category that carries no requirement to demonstrate purity, identity, or freedom from contamination. Because it is not an approved medicine, products labeled BPC-157 sit in a regulatory gap in many countries, and actual content may differ from the label. Sports organizations list it among prohibited substances, so its presence in an athlete's sample can produce a doping finding regardless of how the material was obtained.
BPC-157 is a synthetic peptide of fifteen amino acids, written as GEPPPGKPADDAGLV, whose sequence matches part of a larger protein identified in human gastric juice. That parent protein was described in stomach-secretion research, and the fifteen-residue fragment was named body protection compound, which gives the peptide its common label. Material used in experiments is produced by solid-phase peptide synthesis rather than extracted from tissue. The reported molecular weight is about 1419 daltons, and the chain contains several proline residues, a feature that appears in discussions of its resistance to enzymatic breakdown.
Most published findings come from rodent models, where the peptide has been examined in wound-healing, gastrointestinal-lesion, tendon, and vascular-injury preparations. A smaller number of early human studies have been reported, chiefly in inflammatory bowel conditions, but the public record is short and has not led to marketing approval in the United States or the European Union. Reviewers therefore classify the compound as investigational, and whether animal results carry over to people remains an open question rather than a settled one.
Direct human evidence is scarce. One trial in ulcerative colitis delivered the compound by enema and produced limited publicly reported results without a clear benefit. The compound is not an approved medicine in most jurisdictions. In many markets it is sold as a research chemical; in others it falls under prescription or controlled categories. Regulators have not confirmed any claimed medical use, and product labels rarely undergo premarket review.
Most published reports describe experiments in rodents rather than in people. These studies examine outcomes in tendons, ligaments, bone, stomach lining, and intestinal tissue. In rat and mouse models, a frequently reported effect is faster healing or reduced damage. Sample sizes are usually small, and a substantial share of the work originates from a small number of research groups. Independent replication is limited, so how far the findings extend to humans remains an open question.
Purity is ordinarily reported as a percentage from reverse-phase high-performance liquid chromatography, where the area of the main peak is compared with the total peak area. Identity is confirmed by mass spectrometry, since the measured mass can be checked against the value calculated from the sequence. Some certificates also include amino acid analysis or sequence confirmation by tandem mass spectrometry. A single purity number does not describe the profile of related impurities, so the underlying chromatogram and spectrum usually carry more information than the headline figure.
Material of this kind is sold for laboratory research, and labels typically state that it is not intended for human or veterinary use. In many countries it is not an approved medicine, and sports antidoping rules place it among prohibited non-approved substances. Buyers commonly review a certificate of analysis, an independent test report, and the declared storage conditions. Batch-to-batch variation in purity and in counterion content is possible, and how much that variation affects experimental outcomes remains an open question.
Lyophilized peptide is normally kept at minus twenty degrees Celsius or colder, away from light and moisture. Powder held under those conditions is widely treated as stable for long periods, although published stability studies for this exact sequence are sparse and often come from suppliers rather than independent laboratories. Once dissolved, solutions are generally handled cold and used within a short window, because peptide bonds can hydrolyze over time. Repeated freeze-thaw cycles are usually avoided to limit losses, and exact shelf-life figures depend on the buffer and the concentration involved.
Physical descriptions in supplier documents and papers usually list the compound as a white to off-white powder. It dissolves readily in water and in common aqueous buffers, and solutions are often prepared fresh before an experiment. Molecular mass near 1419 daltons helps verify identity during mass spectrometry. The powder is somewhat hygroscopic, so moisture exposure can alter the measured mass of a sample. Purity is typically reported as a percentage from chromatographic analysis.
BPC-157 is a synthetic fifteen-amino-acid peptide whose sequence is GEPPPGKPADDAGLV. Its name derives from the phrase body protection compound, a term applied to a protein fraction originally detected in human gastric juice. The short peptide is not that full protein; it corresponds to a stable fragment of the larger molecule. Researchers frequently describe it as a pentadecapeptide because it contains exactly fifteen residues. Its neutral molecular mass is approximately 1419 daltons.
Classical (or "Werner Complexes"): Ligands in classical coordination chemistry bind to metals, almost exclusively, via their lone pairs of electrons residing on the main-group atoms of the ligand. Typical ligands are H2O, NH3, Cl−, CN−, en. Some of the simplest members of such complexes are described in metal aquo complexes, metal ammine complexes, Examples: [Co(edta)]−, [Co(NH3)6]3+, [Fe(C2O4)3]3− Organometallic chemistry: Ligands are organic (alkenes, alkynes, alkyls) as well as "organic-like" ligands such as phosphines, hydride, and CO. Example: (C5H5)Fe(CO)2CH3 Bioinorganic chemistry: Ligands are those provided by nature, especially including the side chains of amino acids, and many cofactors such as porphyrins. Example: hemoglobin contains heme, a porphyrin complex of iron Example: chlorophyll contains a porphyrin complex of magnesium Many natural ligands are "classical" especially including water. Cluster chemistry: Ligands include all of the above as well as other metal ions or atoms as well. Example Ru3(CO)12 In some cases there are combinations of different fields: Example: [Fe4S4[S(cysteinyl)]4]2−, in which a cluster is embedded in a biologically active species. Mineralogy, materials science, and solid state chemistry – as they apply to metal ions – are subsets of coordination chemistry in the sense that the metals are surrounded by ligands. In many cases these ligands are oxides or sulfides, but the metals are coordinated nonetheless, and the principles and guidelines discussed below apply. In hydrates, at least some of the ligands are water molecules.
Following oral intake, bempedoic acid reaches highest blood plasma concentrations after 3.5 hours. Food does not affect its absorption. When in the bloodstream, 99.3% of the substance are bound to plasma proteins. About a fifth of the substance is reversibly converted by an aldo-keto reductase enzyme to a metabolite (called ESP15228) that is also pharmacologically active in form of its coenzyme A–thioester. Of ESP15228, 99.2% are bound to plasma proteins. Both bempedoic acid and the metabolite are inactivated by glucuronidation of their carboxylic acid groups. Bempedoic acid has a biological half-life of 21±11 hours. Over 95% of the substance are excreted in form of metabolites; about 70% with the urine and 30% with the feces.
Afamelanotide is a synthetic tridecapeptide and a structural analogue of α-melanocyte stimulating hormone (α-MSH). It is a melanocortin receptor agonist and binds predominantly to the MC1 receptor. Its binding lasts longer than that of α-MSH. This results in part from afamelanotide's resistance to immediate degradation by serum or proteolytic enzymes. It is thought to cause skin darkening by binding to the MC1 receptor which in turn drives melanogenesis. It has a short half-life of approximately 30 minutes. After administration with implantation into the skin, the majority of the drug is released within two days, with 90% released by the fifth day. By the tenth day, no drug is detectable in plasma. The details of drug distribution, metabolism and excretion remain unclear (as of 2026), but since it is a small peptide with a short half-life, it is expected that it is quickly broken down into shorter peptide fragments and amino acids.
=== Ammunition === Most military use of depleted uranium has been as 30 mm ordnance, primarily the 30 mm PGU-14/B armor-piercing incendiary round from the GAU-8 Avenger cannon of the A-10 Thunderbolt II used by the United States Air Force. 25 mm DU rounds have been used in the M242 gun mounted on the U.S. Army's Bradley Fighting Vehicle and the Marine Corps's LAV-25. The U.S. Marine Corps uses DU in the 25 mm PGU-20 round fired by the GAU-12 Equalizer cannon of the AV-8B Harrier, and in the 20 mm M197 gun mounted on AH-1 Cobra helicopter gunships. The United States Navy's Phalanx CIWS's M61 Vulcan Gatling gun used 20 mm armor-piercing penetrator rounds with discarding plastic sabots and a core made using depleted uranium, however they later changed to using tungsten penetrators.
Sources: en.wikipedia.org
=== Wes: The Meat-Stick Bully === First aired: 24 September 2009 Victim Chris has a problem with a tobacco spittin', hockey playing Texan and self-proclaimed "meat-stick", Wes. Mayhem enlists Tony Bonello to put this bully in his place. He was submitted 4 times and knocked out, but with an illegal head kick. Wes actually managed to knock down Tony Bonello which, apparently, upset the MMA fighter enough for him to break the rules. The kick to the head was hard enough that Wes could not remember where he was, or any of the fight. Because of the illegal kick, the bully received the $5,000 for that round. However, Wes refused it, stating "A knockout's a knockout," and then apologized to Chris by giving the money to him. Mayhem refers to Chris as his favorite victim because he is cute and adorable.
Infected dogs carry the highest bacterial load of B. canis after 1-6 months after infection. Infected neutered animals are not able to display reproductive symptoms, however both intact and neutered dogs are able to shed B. canis in urine. This means that both neutered and intact dogs are able to transmit the disease via urine. B. canis is found to be localized in the prostate of male dogs, thus transmitting through the urine in both intact and neutered males. It has been suggested that male dogs carry higher concentrations of the bacteria when compared to female dogs due contamination from seminal fluid. Neutered dogs are also capable of shedding the bacteria in their saliva and nasal secretions. B. canis is the least common cause of Brucellosis in humans. Transmission to humans is rarely diagnosed but is possible. It can be transmitted via bodily fluids and aborted material. Signs and symptoms are very non-specific, such as fever, joint pain, and fatigue. The disease can also be debilitating, causing conditions such as endocarditis, splenomegaly, or neurologic symptoms.
== Career and research == Springer then pursued postdoctoral work on antigen-specific T lymphocyte helper factors at the University of Cambridge. Within six months, Springer failed to replicate key experiments and discovered fraudulent work, followed by a retraction. He switched to work under César Milstein at the University of Cambridge and the MRC Laboratory of Molecular Biology, soon after the development of monoclonal antibody technology. Milstein personally taught Springer how to make monoclonal antibodies, and with his first set of hybridomas in hand, Springer returned to the United States after another six months. Before his postdoc, Springer was offered a position as Assistant Professor at Harvard Medical School by Baruj Benacerraf, the Chair of Pathology, and joined that department in 1977. He was recruited to the Dana–Farber Cancer Institute in 1981 after Benacerraf became its President, as Chief of the Laboratory of Membrane Immunochemistry, and was promoted to Associate Professor in 1983. In 1988, Springer was recruited by Fred Rosen to move his lab to and become Vice President of the Center for Blood Research. He was involved in planning its new space in the Warren Alpert Building and recruiting faculty. These included Ulrich von Andrian, Jose Carlos Gutierrez-Ramos, Rick van Etten, Anjana Rao, Denisa Wagner, and Judy Lieberman. Later, he led searches that recruited Sun Hur, Wesley Wong, and Hao Wu. Four of these recruits were subsequently elected to the National Academy of Sciences. Springer became the Latham Family Professor in 1989.
=== Acquisition by Take-Two Interactive (2024–present) === Take-Two Interactive announced its plans to acquire Gearbox Entertainment and its intellectual properties from Embracer Group for $460 million on March 28, 2024, to be added under the 2K label. The acquisition also includes Gearbox Software with its satellite studios and Gearbox Publishing. Embracer will retain Gearbox San Francisco, Gearbox Shanghai, Lost Boys Interactive, Captured Dimensions, and Cryptic Studios, along with publishing rights to Remnant, Hyper Light Breaker, and other unannounced titles. Less than a day after the announcement, it was reported that an unknown number of employees were laid off from Gearbox. On June 12, 2024, Take-Two Interactive closed the Gearbox Software transaction.
=== 2008 WTO decision === In November 2004, the EU requested WTO consultations, claiming that the United States should remove its retaliatory measures since the EU had removed the measures found to be WTO-inconsistent in the original case. In 2005, the EU initiated new WTO dispute settlement proceedings against the US and Canada, and a March 2008 panel report cited fault with all three parties (EU, United States, and Canada) on various substantive and procedural matters. In October 2008, the WTO Appellate Body issued a mixed ruling that allows continued imposition of trade sanctions on the EU by the United States and Canada, but also allowed the EU to continue its import ban. In November 2008, the EU filed a new WTO challenge following the announcement by the USTR that it was seeking comment on possible modification of the list of EU products subject to increased tariffs, and in January 2009 the USTR announced changes to the list of EU products subject to increased tariffs. In September 2009, the United States and the European Commission signed a memorandum of understanding, which established a new EU duty-free import quota for grain-fed, high quality beef (HQB) as part of a compromise solution.
Sources: en.wikipedia.org
Human data are limited. Most evidence comes from animal experiments and from small or uncontrolled reports. The absence of large trials means clinical effects and safety are not firmly established.
Frequently measured outcomes include wound healing, blood vessel growth, and tissue repair markers. Some work examines gastrointestinal protection. The choice of endpoint depends on the model used.
Different routes of administration and different animal models require different amounts. Studies also use varied timelines and measurement methods. This variation makes it difficult to combine results into a single standardized figure.
Low temperature slows the chemical reactions, such as oxidation and hydrolysis, that break down a peptide chain. Water and oxygen are the main drivers of degradation, so a cold and dry environment extends usable life. Actual shelf life depends on the batch, the salt form, and the container.